PA
ORC

PharVision Advisers’s Orchid Island Capital ORC Stock Holding History

PharVision Advisers’s Portfolio ORC Stock Details ORC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$128K Sell
18,180
-31,357
-63% -$237K 1.3% 25
2025
Q4 		$357K Buy
49,537
+15,812
+47% +$115K 0.18% 183
2025
Q3 		$236K Sell
33,725
-13,770
-29% -$97.9K 0.13% 371
2025
Q2 		$333K Buy
47,495
+26,647
+128% +$185K 0.48% 61
2025
Q1 		$157K Buy
+20,848
New +$171K 0.22% 226

Other funds holding ORC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's ORC Position: Q1 2026 in Review

PharVision Advisers reduced its Orchid Island Capital (ORC) stake by 63% in Q1 2026, selling an estimated $237K and leaving 18,180 shares worth $128K. The position accounts for 1.3% of the portfolio, ranked #25.

PharVision Advisers first reported a position in ORC in Q1 2025 and has held it in 5 quarters since. The position peaked at $357K in Q4 2025. 195 funds tracked by Wall St. Rank hold ORC as of Q1 2026.

  • PharVision Advisers held 18,180 shares of Orchid Island Capital worth $128K as of Q1 2026.
  • PharVision Advisers sold 31,357 Orchid Island Capital shares in Q1 2026, an estimated $237K.
  • Orchid Island Capital made up 1.3% of PharVision Advisers's portfolio in Q1 2026, its #25 holding.
  • PharVision Advisers first reported a position in Orchid Island Capital in Q1 2025 and has held it in 5 quarters since.
  • PharVision Advisers's Orchid Island Capital position peaked at $357K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Orchid Island Capital as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.